A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides

European Journal of Pharmacology

Volumn 365, Issue 2-3, 1999, Pages 175-182

  Cappendijk, Susanne L T ^a   Hurd, Yasmin L ^a   Nylander, Ingrid ^b   Van Ree, Jan M ^c   Terenius, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Craving; Dynorphin; Enkephalin; Self administration; Substance P; Withdrawal

Indexed keywords

COCAINE; DIAMORPHINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COCAINE; DYNORPHINS; ENKEPHALINS; HEROIN; INJECTIONS, INTRAVENOUS; MALE; NEUROPEPTIDES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SELF ADMINISTRATION; SUBSTANCE P; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 0032911028     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00874-7     Document Type: Article

References (33)

1. Altman J., Everitt B.J., Glautier S., Markou A., Nutt D., Oretti R., Phillips G.D., Robbins T.W. The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology. 125:1996;285-345.
2. Bergström L., Terenius L. Enkephalin levels decrease in rat striatum during morphine abstinence. Eur. J. Pharmacol. 60:1979;349-352.
3. Bergström L., Christensson I., Folkesson R., Stenström B., Terenius L. An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P. Life Sci. 33:1983;1613-1619.
4. Cappendijk S.L.T., Fekkes D., Dzoljic M.R. The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine. Behav. Brain Res. 65:1994;117-119.
5. Carr K.D. Feeding, drug abuse, and the sensitization of reward by metabolic feed. Neurochem. Res. 21:1996;1455-1467.
6. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alter striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
7. Daunais J.B., McGinty J.F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Mol. Brain Res. 29:1995;201-210.
8. Daunais J.B., Roberts D.C.S., McGinty J.F. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. NeuroReport. 4:1993;543-546.
9. de Vry J., Donselaar I., van Ree J.M. Food deprivation and acquisition of cocaine self-administration in rats: effect of naltrexone and haloperidol. J. Pharmacol. Exp. Ther. 251:1989;735-740.
10. Engber T.M., Boldry R.C., Kuo S., Chase T.N. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res. 502:1992;261-268.
11. Gispen W.H., Schotman P., de Kloet E.R. Brain RNA and hypophysectomy. Neuroendocrinology. 9:1972;285-296.
12. Hong J.S., McGinty J.F., Grimes L., Kanamatsu T., Obie J., Mitchell C.L. Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors (review). NIDA Res. Monogr. 82:1988;48-66.
13. Hurd Y.L., Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol. Brain Res. 16:1992;97-104.
14. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13:1992;165-170.
15. Kalant, H., 1978. Behavioral criteria for tolerance and physical dependence. In: Fishman, J. (Ed.), The Basis of Addiction. Dahlem Konferenzen, Berlin, pp. 199-220.
16. Koob G.F., Caine S.B., Markou A., Pulvirenti L., Weiss F. Role for the mesocortical dopamine system in the motivating effects of cocaine. NIDA Res. Monogr. 145:1994;1-18.
17. Latimer L.G., Duffy P., Kalivas P.W. μ-Opioid involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:1987;328-337.
18. Markou A., Weiss F., Gold L.H., Caine S.B., Schulteis G., Koob G.F. Animal models of drug craving. Psychopharmacology. 112:1993;163-182.
19. Nylander I., Terenius L. Dopamine receptors mediate alterations in striatonigral dynorphin and substance P pathways. Neuropharmacology. 26:1987;1295-1302.
20. Nylander I., Vlaskovska M., Terenius L. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology. 118:1995;391-400.
21. Nylander I., Vlaskovska M., Terenius L. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Res. 683:1995;25-35.
22. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates: 1992 (review). Peptides. 14:1993;1339-1378.
23. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
24. Romualdi P., Lesa G., Ferri S. Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain. Brain Res. 563:1991;132-136.
25. Romualdi P., Lesa G., Donatini A., Ferri S. Long-term exposure to opioid antagonist upregulates prodynorphin gene expression in rat brain. Brain Res. 672:1995;42-47.
26. Sivam S.P. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp. Ther. 250:1989;818-824.
27. Smiley P.L., Johnson M., Bush L., Gibb J.W., Hanson G.R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253:1990;938-943.
28. Spangler R., Zhou Y., Maggos C.E., Schlussman S.D., Ho A., Kreek M.J. Prodynorphin, proenkephalin and κ-opioid receptor mRNA responses to acute 'binge' cocaine. Mol. Brain Res. 44:1997;139-142.
29. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
30. Sweep C.G.J., Wiegant V.M., de Vry J., van Ree J.M. β-Endorphin in brain limbic structures as neurochemical correlate of psychic dependence on drugs. Life Sci. 44:1989;1133-1140.
31. Trujillo K.A., Bronstein D.M., Sanchez I.O., Akil H. Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides. Brain Res. 698:1995;69-78.
32. Unterwald E.M., Horne-King J., Kreek M.J. Chronic cocaine alters brain μ-opioid receptors. Brain Res. 584:1993;314-318.
33. van Ree J.M., Slangen J.L., de Wied D. Intravenous self-administration of drugs in rats. J. Pharmacol. Exp. Ther. 204:1978;547-557.